Liminal BioSciences Inc. LMNL

RE:RE:price targets (repost)

[GunnerG]

Piper Sandler downgraded from $22 to $4.50 two days before the green light.

Your information below is at least 4-5 months old.

realstocky wrote: just to  mention these are before FDA green light last friday and excluding piper new price target issued couple days before friday FDA go ahead...

realstocky wrote:

https://www.marketbeat.com/stocks/NASDAQ/LMNL/price-target/

 

LMNL Consensus Rating:	Hold	Hold	Hold	Hold
LMNL Consensus Rating Score:	2.20	2.25	2.33	2.00
LMNL Analyst Ratings:	1 Sell Rating(s) 2 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 1 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)
LMNL Consensus Price Target:	$18.00	$18.00	$21.50	$21.00
LMNL Price Target Upside:	333.73% upside	283.39% upside	425.67% upside	N/A

 

-----------------------------

average price target moved from 11$ to 16,50$;) Buy low, sell high...

LMNL Analyst Research

LMNL Analyst Ratings

Consensus Buy

Based on 4 analysts offering recommendations for lmnl in the last 3 months.

Analyst Firms Making Recommendations

• BLOOM BURTON&CO
• H C WAINWRIGHT
• LEEDE JONES GAB
• PIPER SANDLER

Analyst

$16.5

Based on analysts offering 12 month price targets for LMNL in the last 3 months. The average price target is $16.5 with a high estimate of $22 and a low estimate of $11. Sign in to your SmartPortfolio to see more analyst recommendations.

 

https://www.nasdaq.com/market-activity/stocks/lmnl/analyst-research